Non-chemotherapy drug-induced neutropenia: key points to manage the challenges.
Curtis BR.
Hematology Am Soc Hematol Educ Program. 2017 Dec 8;2017(1):187-193. doi: 10.1182/asheducation-2017.1.187.
Drug-induced immune neutropenia/agranulocytosis.
Curtis BR.
Immunohematology. 2014;30(2):95-101.
Drug-Induced Neutropenia During Treatment of Non-Neoplastic Dermatologic Diseases: A Review.
Hsieh CY, Tsai TF.
Clin Drug Investig. 2020 Oct;40(10):915-926. doi: 10.1007/s40261-020-00956-w.
Psychotropic drug-induced neutropenia.
Duggal HS, Singh I.
Drugs Today (Barc). 2005 Aug;41(8):517-26. doi: 10.1358/dot.2005.41.8.893629.
Management of drug-induced neutropenia, thrombocytopenia, and anaemia after solid organ transplantation: A comprehensive review.
Baradaran H, Hashem Zadeh A, Dashti-Khavidaki S, Laki B.
J Clin Pharm Ther. 2022 Dec;47(12):1895-1912. doi: 10.1111/jcpt.13775. Epub 2022 Oct 17.
Non-chemotherapy drug-induced neutropenia - an update.
Andrès E, Mourot-Cottet R.
Expert Opin Drug Saf. 2017 Nov;16(11):1235-1242. doi: 10.1080/14740338.2017.1376645. Epub 2017 Sep 17.
Drug-induced immune neutropenia.
Stroncek DF.
Transfus Med Rev. 1993 Oct;7(4):268-74. doi: 10.1016/s0887-7963(93)70146-7.
Drug-induced neutropenia.
[No authors listed]
Lancet. 1983 Apr 16;1(8329):857-8.
Nonchemotherapy drug-induced neutropenia and agranulocytosis: could medications be the culprit?
Pick AM, Nystrom KK.
J Pharm Pract. 2014 Oct;27(5):447-52. doi: 10.1177/0897190014546115. Epub 2014 Aug 14.
Antipsychotic drug-induced neutropenia: results from the AMSP drug surveillance program between 1993 and 2016.
Glocker C, Grohmann R, Burkhardt G, Seifert J, Bleich S, Held T, Toto S, Stübner S, Schüle C.
J Neural Transm (Vienna). 2023 Feb;130(2):153-163. doi: 10.1007/s00702-023-02589-7. Epub 2023 Jan 18.
